vbi-1901
bridgebio
['gbm', 'bridge bio']
bcbn feed: vbi vaccines presents updated phase 2a tumor response and overall survival data for vbi-1901 in recurrent gbm at the 2022 asco annual meeting: cambridge, mass. (business wire) vbi vaccines ... #boston #biotech 
Boston Cambridge Biotech Networks: Building a community and providing news and events for the local life science industry. For jobs follow @bcbnjobs